- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02306356
Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting
January 18, 2016 updated by: Eva Serlachius, Karolinska Institutet
An open trial will be conducted at the Child and Mental Health Service (CAMHS) unit in the rural county Jämtland in Sweden to test the feasibility and efficacy of Internet-delivered Cognitive Behavior Therapy (ICBT) for children with anxiety disorders in a clinical setting.
20 children with a principal diagnosis of Generalized Anxiety Disorder (GAD), separation anxiety, specific phobia and their parents will be recruited from the CAMHS-center in Östersund.
They will receive 12 weeks of therapist-supported ICBT and will be assessed by clinician ratings and child- and parent-reports at baseline, post-treatment and 3 month follow-up.
The primary outcome measures the Clinical Global Impressions - Severity scale (CGI-S).
Secondary outcome measures include clinician rated global functioning, and child and parent-rated anxiety and functioning.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jämtland
-
Östersund, Jämtland, Sweden, 83183
- Child and Adolescent Mental Health Services Östersund
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 8-12 years of age
- Fulfilling diagnostic criteria for Generalized Anxiety Disorder (GAD), Separation anxiety, Specific phobia
- Ability to read and write Swedish
- Daily access to the internet
- A parent that is able to co-participate in the treatment
- Participants on psychotropic medication must have been on a stable dose for the last 3 months prior to baseline assessment
Exclusion Criteria:
- Diagnosed autism spectrum disorder or Attention-deficit/hyperactivity disorder (ADHD), or principal primary disorder other than GAD, Separation anxiety, Specific phobia
- Acute/severe psychiatric problems such as suicidal risk or severe depression
- Ongoing psychological treatment for anxiety disorders
- Ongoing child custody dispute or abuse in the family
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interventional
Behavioral: Internet-delivered Cognitive Behavior Therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Clinical Global Impressions - severity (CGI-S)
Time Frame: baseline, post-treatment (12 weeks), follow-up (3 months)
|
Change in CGI-s from baseline to post-treatment and follow-up
|
baseline, post-treatment (12 weeks), follow-up (3 months)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Children´s Global Assessment Scale (CGAS
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Spence Child Anxiety Scale C/P (SCAS-C/P)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Penn State Worry Questionnaire (PSWQ)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Separation Anxiety Index (SAI)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Fear Survey Schedule for Children - Revised (FSSC-R)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Child Sheehan Disability Scale (CSDS)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Child Depression Inventory (CDI)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Hospital Anxiety Depression Scale (HAD)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Client Satisfaction Scale (CSS)
Time Frame: post-treatment (12 weeks)
|
post-treatment (12 weeks)
|
Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Baseline, post-treatment (12 weeks), follow-up (3 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
September 27, 2014
First Submitted That Met QC Criteria
December 2, 2014
First Posted (Estimate)
December 3, 2014
Study Record Updates
Last Update Posted (Estimate)
January 20, 2016
Last Update Submitted That Met QC Criteria
January 18, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/1225-31/4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Xijing HospitalRecruitingGeneralized Anxiety DisorderChina
-
Sichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingGeneralized Anxiety Disorder
-
Hospital de Clinicas de Porto AlegreRecruitingGeneralized Anxiety DisorderBrazil
-
University of California, Los AngelesMedical University of South Carolina; Massachusetts General HospitalRecruitingGeneralized Anxiety DisorderUnited States
-
Shahid Beheshti University of Medical SciencesCompletedGeneralized Anxiety DisorderIran, Islamic Republic of
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedGeneralized Anxiety DisorderCanada
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
The Canadian College of Naturopathic MedicineMassachusetts General Hospital; McGill University; Mitacs; Ekhagastiftelsen; Netherlands... and other collaboratorsActive, not recruitingGeneralized Anxiety DisorderCanada
Clinical Trials on Internet-delivered Cognitive Behavior Therapy
-
Karolinska InstitutetRegion StockholmRecruitingGeneralized Anxiety DisorderSweden
-
Linkoeping UniversityKarolinska Institutet; Uppsala University; Umeå University; Stockholm UniversityUnknownBrain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder (UMEII)Anxiety Disorders | Social Anxiety DisorderSweden
-
Karolinska InstitutetCompletedObsessive Compulsive Disorder | Autism Spectrum DisorderSweden
-
Karolinska InstitutetUppsala UniversityCompleted
-
Karolinska InstitutetCompletedObsessive-Compulsive DisorderSweden
-
Eva SerlachiusRegion StockholmCompletedObsessive-Compulsive DisorderSweden
-
Karolinska InstitutetCompletedFunctional Abdominal Pain DisordersSweden
-
Karolinska InstitutetCompletedObsessive-Compulsive DisorderSweden
-
Karolinska InstitutetCompletedIrritable Bowel Syndrome | Functional Gastrointestinal DisordersSweden
-
Karolinska InstitutetRegion Stockholm; Aleris Helse; Allmänna arvsfonden; Königska-Söderströmska sjukhemmetCompletedIrritable Bowel SyndromeSweden